AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 242: H776-H784, 1982;
0363-6135/82 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pfeffer, J. M.
Right arrow Articles by Braunwald, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pfeffer, J. M.
Right arrow Articles by Braunwald, E.

AJP - Heart and Circulatory Physiology, Vol 242, Issue 5 776-H784, Copyright © 1982 by American Physiological Society

ARTICLES

Favorable effects of therapy on cardiac performance in spontaneously hypertensive rats

J. M. Pfeffer, M. A. Pfeffer, P. Fletcher, M. C. Fishbein and E. Braunwald

To determine whether chronic antihypertensive therapy reduces cardiac mass and improves performance in spontaneously hypertensive rats (SHR) with marked left ventricular hypertrophy and evidence of cardiac dysfunction, 12-mo-old male and female SHR and age- and sex-matched normotensive rats (NORM) were treated for 6 mo with either tap water or tap water containing hydralazine or guanethidine. Cardiac performance was assessed by the peak stroke volume and cardiac indices attained during volume loading and by the maximum left ventricular pressure developed during an aortic occlusion. Passive diastolic pressure-volume curves were obtained in the potassium-arrested heart. Treatment prevented the progression of left ventricular hypertrophy in SHR and the marked deterioration in peak pumping ability observed in untreated male SHR and the modest impairment observed in female SHR. The peak developed pressure of both the male and female treated SHR was reduced toward that of NORM and was associated with a reduction in the left ventricular mass-to-volume ratio toward that of NORM. Thus chronic therapy with either hydralazine or guanethidine reduced cardiac mass and prevented the deterioration in cardiac pumping performance observed in SHR with sustained hypertension and marked cardiac hypertrophy.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M.-C. Battista, L. L. Oligny, J. St-Louis, and M. Brochu
Intrauterine growth restriction in rats is associated with hypertension and renal dysfunction in adulthood
Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E124 - E131.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
K. F. Adams Jr, C. A. Sueta, M. Gheorghiade, C. M. O'Connor, T. A. Schwartz, G. G. Koch, B. Uretsky, K. Swedberg, W. McKenna, J. Soler-Soler, et al.
Gender Differences in Survival in Advanced Heart Failure : Insights From the FIRST Study
Circulation, April 13, 1999; 99(14): 1816 - 1821.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. F. Mitchell, M. A. Pfeffer, P. V. Finn, and J. M. Pfeffer
Equipotent Antihypertensive Agents Variously Affect Pulsatile Hemodynamics and Regression of Cardiac Hypertrophy in Spontaneously Hypertensive Rats
Circulation, December 1, 1996; 94(11): 2923 - 2929.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online